Search Results

There are 36292 results for: content related to: Reply:

  1. You have free access to this content
    Combined effects of different interleukin-28B gene variants on the outcome of dual combination therapy in chronic hepatitis C virus type 1 infection

    Hepatology

    Volume 55, Issue 6, June 2012, Pages: 1700–1710, Janett Fischer, Stephan Böhm, Markus Scholz, Tobias Müller, Heiko Witt, Jacob George, Christoph Sarrazin, Simone Susser, Eckart Schott, Vijayaprakash Suppiah, David R. Booth, Graeme J. Stewart, Florian van Bömmel, Annika Brodzinski, Balazs Fülöp, Pascal Migaud and Thomas Berg

    Article first published online : 18 APR 2012, DOI: 10.1002/hep.25582

  2. You have free access to this content
    AASLD Abstracts

    Hepatology

    Volume 56, Issue S1, October 2012, Pages: 191A–1144A,

    Article first published online : 1 OCT 2012, DOI: 10.1002/hep.26040

  3. You have free access to this content
    Meta-analysis: IL28B polymorphisms predict sustained viral response in HCV patients treated with pegylated interferon-α and ribavirin

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 2, July 2012, Pages: 91–103, Y. Chen, H.-X. Xu, L.-J. Wang, X.-X. Liu, R. I. Mahato and Y.-R. Zhao

    Article first published online : 16 MAY 2012, DOI: 10.1111/j.1365-2036.2012.05131.x

  4. You have free access to this content
    Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C

    Hepatology

    Volume 53, Issue 4, April 2011, Pages: 1118–1126, Davide Bitetto, Giovanna Fattovich, Carlo Fabris, Elisa Ceriani, Edmondo Falleti, Ezio Fornasiere, Michela Pasino, Donatella Ieluzzi, Annarosa Cussigh, Sara Cmet, Mario Pirisi and Pierluigi Toniutto

    Article first published online : 7 APR 2011, DOI: 10.1002/hep.24201

  5. You have free access to this content
    Hepatitis C pharmacogenetics: State of the art in 2010

    Hepatology

    Volume 53, Issue 1, January 2011, Pages: 336–345, Nezam H. Afdhal, John G. McHutchison, Stefan Zeuzem, Alessandra Mangia, Jean-Michel Pawlotsky, Jeffrey S. Murray, Kevin V. Shianna, Yasuhito Tanaka, David L. Thomas, David R. Booth, David B. Goldstein and for the Pharmacogenetics and Hepatitis C Meeting Participants

    Article first published online : 12 JAN 2011, DOI: 10.1002/hep.24052

  6. The Role of Pharmacogenetics in the Treatment of Chronic Hepatitis C Infection

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 34, Issue 2, February 2014, Pages: 185–201, Marina Kawaguchi-Suzuki and Reginald F. Frye

    Article first published online : 30 SEP 2013, DOI: 10.1002/phar.1349

  7. Early anemia and rapid virological response improve the predictive efficiency of IL28B-genotype for treatment outcome to antiviral combination therapy in patients infected with chronic HCV genotype 1

    Journal of Medical Virology

    Volume 84, Issue 8, August 2012, Pages: 1208–1216, Ahmad Amanzada, Simon Schneider, Federico Moriconi, Alexander Lindhorst, Thomas Suermann, David H. van Thiel, Sabine Mihm and Giuliano Ramadori

    Article first published online : 18 JUN 2012, DOI: 10.1002/jmv.23323

  8. You have free access to this content
    Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for IFNL3 (IL28B) Genotype and PEG Interferon-α–Based Regimens

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 2, February 2014, Pages: 141–146, A J Muir, L Gong, S G Johnson, M T M Lee, M S Williams, T E Klein, K E Caudle and D R Nelson

    Article first published online : 4 OCT 2013, DOI: 10.1038/clpt.2013.203

  9. Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 1, January 2014, Pages: 179–184, Stuart K Roberts, Joanne Mitchell, Reynold Leung, David Booth, Steven Bollipo, George Ostapowicz, Andrew Sloss, Geoffrey W McCaughan, Gregory J Dore, Alexander Thompson, Darrell HG Crawford, William Sievert, Martin Weltman, Wendy Cheng, Jacob George and on behalf of the Australian Liver Association Clinical Research Network

    Article first published online : 19 DEC 2013, DOI: 10.1111/jgh.12424

  10. You have free access to this content
    Role of IL28B for chronic hepatitis C treatment toward personalized medicine

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 2, February 2014, Pages: 241–249, Kentaro Matsuura, Tsunamasa Watanabe and Yasuhito Tanaka

    Article first published online : 27 JAN 2014, DOI: 10.1111/jgh.12475

  11. Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 2, February 2012, Pages: 279–285, José M Ladero, Elena García Martin, Cristina Fernández, Miguel Carballo, María J Devesa, Carmen Martínez, Avelina Suárez, Manuel Díaz-Rubio and José A Agúndez

    Article first published online : 20 JAN 2012, DOI: 10.1111/j.1440-1746.2011.06834.x

  12. Hepatitis C virus and interferon type III (interferon-λ3/interleukin-28B and interferon-λ4): genetic basis of susceptibility to infection and response to antiviral treatment

    Clinical Microbiology and Infection

    Volume 20, Issue 12, December 2014, Pages: 1237–1245, E. Riva, C. Scagnolari, O. Turriziani and G. Antonelli

    Article first published online : 12 DEC 2014, DOI: 10.1111/1469-0691.12797

  13. You have free access to this content
    IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection

    Hepatology

    Volume 53, Issue 3, March 2011, Pages: 746–754, Amir Moghaddam, Espen Melum, Nils Reinton, Helmer Ring-Larsen, Hans Verbaan, Kristian Bjøro and Olav Dalgard

    Article first published online : 2 MAR 2011, DOI: 10.1002/hep.24154

  14. IFNL3 (IL28B) and IFNL4 polymorphisms are associated with treatment response in Thai patients infected with HCV genotype 1, but not with genotypes 3 and 6

    Journal of Medical Virology

    Volume 86, Issue 9, September 2014, Pages: 1482–1490, Srunthron Akkarathamrongsin, Vo Duy Thong, Sunchai Payungporn, Kittiyod Poovorawan, Phisit Prapunwattana, Yong Poovorawan and Pisit Tangkijvanich

    Article first published online : 30 APR 2014, DOI: 10.1002/jmv.23957

  15. You have free access to this content
    Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype

    HIV Medicine

    Volume 12, Issue 8, September 2011, Pages: 487–493, K Neukam, J Nattermann, N Rallón, A Rivero, A Caruz, J Macías, M Vogel, JM Benito, Á Camacho, JA Mira, C Schwarze-Zander, P Barreiro, A Martínez, JK Rockstroh, V Soriano and JA Pineda

    Article first published online : 6 MAR 2011, DOI: 10.1111/j.1468-1293.2011.00912.x

  16. You have free access to this content
    Impact of cohort size and host factors on combined analysis of interleukin 28B rs12979860 and rs8099917 in hepatitis C virus infection

    Hepatology

    Volume 57, Issue 1, January 2013, Pages: 416–417, Janett Fischer, Stephan Böhm, Jacob George, Christoph Sarrazin and Thomas Berg

    Article first published online : 7 JAN 2013, DOI: 10.1002/hep.25923

  17. Variation in genes encoding for interferon λ-3 and λ-4 in the prediction of HCV-1 treatment-induced viral clearance

    Liver International

    Volume 34, Issue 9, October 2014, Pages: 1369–1377, Orazio Palmieri, Antonio M. Ippolito, Maurizio Margaglione, Maria R. Valvano, Domenica Gioffreda, Massimo Fasano, Giovanna D'Andrea, Giuseppe Corritore, Michele Milella, Nicola Andriulli, Filomena Morisco, Lydia Giannitrapani, Anna Latiano, Rosanna Fontana, Pietro Gatti, Paolo Tundo, Michele Barone, Raffaele Cozzolongo, Teresa Santantonio and Angelo Andriulli

    Article first published online : 23 DEC 2013, DOI: 10.1111/liv.12411

  18. IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population

    Journal of Digestive Diseases

    Volume 16, Issue 2, February 2015, Pages: 90–97, Zhi Xia Dong, Hui Juan Zhou, Xiao Gang Xiang, Si Min Guo, Yan Zhuang, Gang De Zhao and Qing Xie

    Article first published online : 24 FEB 2015, DOI: 10.1111/1751-2980.12202

  19. You have free access to this content
    Association of gene expression involving innate immunity and genetic variation in interleukin 28B with antiviral response

    Hepatology

    Volume 55, Issue 1, January 2012, Pages: 20–29, Yasuhiro Asahina, Kaoru Tsuchiya, Masaru Muraoka, Keisuke Tanaka, Yuichiro Suzuki, Nobuharu Tamaki, Yoshihide Hoshioka, Yutaka Yasui, Tomoji Katoh, Takanori Hosokawa, Ken Ueda, Hiroyuki Nakanishi, Jun Itakura, Yuka Takahashi, Masayuki Kurosaki, Nobuyuki Enomoto, Sayuri Nitta, Naoya Sakamoto and Namiki Izumi

    Article first published online : 29 NOV 2011, DOI: 10.1002/hep.24623

  20. Interleukin-28B rs12979860 C allele: Protective against advanced fibrosis in chronic hepatitis C genotype 1 infection

    Journal of Gastroenterology and Hepatology

    Volume 29, Issue 7, July 2014, Pages: 1458–1462, Matthew T Kitson, Jacob George, Gregory J Dore, Reynold Leung, Peter Button, Geoffrey W McCaughan, Darrell H G Crawford, William Sievert, Martin D Weltman, Wendy S C Cheng, Stuart K Roberts and on behalf of the CHARIOT Study Group

    Article first published online : 15 JUL 2014, DOI: 10.1111/jgh.12544